Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Ståhle L[au]:

Comparing sensibility for touch, cold, and warmth in different skin areas. de Rezende Strander N et al. Somatosens Mot Res. (2016)

High-Dose Ribavirin Enhances Early Virological Response in Hepatitis C Genotype 1-Infected Patients. Lindahl K et al. Ther Drug Monit. (2015)

[Follow the dosage instructions when the dose is to be adjusted for renal function]. Ståhle L et al. Lakartidningen. (2013)

Search results

Items: 1 to 50 of 118

1.

Comparing sensibility for touch, cold, and warmth in different skin areas.

de Rezende Strander N, Ståhle L, Hansson PT.

Somatosens Mot Res. 2016 Jun;33(2):118-23. doi: 10.1080/08990220.2016.1197116. Epub 2016 Jul 4.

PMID:
27377987
2.

Ganciclovir concentrations in the cerebral extracellular space after valganciclovir treatment; a case study.

Peredo I, Helldén A, Wolmer-Solberg N, Pohanka A, Stragliotto G, Rahbar A, Ståhle L, Bellander BM, Söderberg-Nauclér C.

BMJ Case Rep. 2015 Dec 15;2015. pii: bcr2014207694. doi: 10.1136/bcr-2014-207694.

3.

Towards Development of a Dermal Pain Model: In Vitro Activation of Rat and Human Transient Receptor Potential Ankyrin Repeat 1 and Safe Dermal Injection of o-Chlorobenzylidene Malononitrile to Rat.

Annas A, Berg AL, Nyman E, Meijer T, Lundgren V, Franzén B, Ståhle L.

Basic Clin Pharmacol Toxicol. 2015 Dec;117(6):375-82. doi: 10.1111/bcpt.12427. Epub 2015 Jul 7.

4.

High-Dose Ribavirin Enhances Early Virological Response in Hepatitis C Genotype 1-Infected Patients.

Lindahl K, Hörnfeld E, Ståhle L, Carlsson T, Weiland O, Parke Å, Schvarcz R.

Ther Drug Monit. 2015 Dec;37(6):745-50. doi: 10.1097/FTD.0000000000000210.

PMID:
25811342
5.

[Follow the dosage instructions when the dose is to be adjusted for renal function].

Ståhle L.

Lakartidningen. 2013 Nov 20-26;110(47):2121. Swedish. No abstract available.

PMID:
24437104
6.

Assessment of interaction potential of AZD2066 using in vitro metabolism tools, physiologically based pharmacokinetic modelling and in vivo cocktail data.

Nordmark A, Andersson A, Baranczewski P, Wanag E, Ståhle L.

Eur J Clin Pharmacol. 2014 Feb;70(2):167-78. doi: 10.1007/s00228-013-1603-8. Epub 2013 Nov 2.

PMID:
24186263
7.

A positron emission tomography study in healthy volunteers to estimate mGluR5 receptor occupancy of AZD2066 - estimating occupancy in the absence of a reference region.

Kågedal M, Cselényi Z, Nyberg S, Raboisson P, Ståhle L, Stenkrona P, Varnäs K, Halldin C, Hooker AC, Karlsson MO.

Neuroimage. 2013 Nov 15;82:160-9. doi: 10.1016/j.neuroimage.2013.05.006. Epub 2013 May 11.

PMID:
23668965
8.

Effects of food or sleep deprivation during civilian survival training on clinical chemistry variables.

Ståhle L, Granström E, Ljungdahl Ståhle E, Isaksson S, Samuelsson A, Rudling M, Sepp H.

Wilderness Environ Med. 2013 Jun;24(2):146-52. doi: 10.1016/j.wem.2012.11.008. Epub 2013 Feb 21.

PMID:
23434165
9.

Circulating human hepcidin-25 concentrations display a diurnal rhythm, increase with prolonged fasting, and are reduced by growth hormone administration.

Troutt JS, Rudling M, Persson L, Ståhle L, Angelin B, Butterfield AM, Schade AE, Cao G, Konrad RJ.

Clin Chem. 2012 Aug;58(8):1225-32. doi: 10.1373/clinchem.2012.186866. Epub 2012 Jun 7.

10.

[Vitamin B1 store is decisive for survival of human beings without food].

Ståhle L.

Lakartidningen. 2012 Mar 14-20;109(11):528-9. Swedish. No abstract available.

PMID:
22530418
11.

Effects of sleep or food deprivation during civilian survival training on cognition, blood glucose and 3-OH-butyrate.

Ståhle L, Ståhle EL, Granström E, Isaksson S, Annas P, Sepp H.

Wilderness Environ Med. 2011 Sep;22(3):202-10. doi: 10.1016/j.wem.2011.02.018.

PMID:
21962046
12.

Long term perturbation of endocrine parameters and cholesterol metabolism after discontinued abuse of anabolic androgenic steroids.

Gårevik N, Strahm E, Garle M, Lundmark J, Ståhle L, Ekström L, Rane A.

J Steroid Biochem Mol Biol. 2011 Nov;127(3-5):295-300. doi: 10.1016/j.jsbmb.2011.08.005. Epub 2011 Aug 22.

PMID:
21884791
13.

Circulating proprotein convertase subtilisin kexin type 9 has a diurnal rhythm synchronous with cholesterol synthesis and is reduced by fasting in humans.

Persson L, Cao G, Ståhle L, Sjöberg BG, Troutt JS, Konrad RJ, Gälman C, Wallén H, Eriksson M, Hafström I, Lind S, Dahlin M, Amark P, Angelin B, Rudling M.

Arterioscler Thromb Vasc Biol. 2010 Dec;30(12):2666-72. doi: 10.1161/ATVBAHA.110.214130. Epub 2010 Sep 30.

PMID:
20884874
14.

A novel mutation in the biliverdin reductase-A gene combined with liver cirrhosis results in hyperbiliverdinaemia (green jaundice).

Gåfvels M, Holmström P, Somell A, Sjövall F, Svensson JO, Ståhle L, Broomé U, Stål P.

Liver Int. 2009 Aug;29(7):1116-24. doi: 10.1111/j.1478-3231.2009.02029.x.

PMID:
19580635
15.

Reexamining transaminase elevation in Phase I clinical trials: the importance of baseline and change from baseline.

Cai Z, Christianson AM, Ståhle L, Keisu M.

Eur J Clin Pharmacol. 2009 Oct;65(10):1025-35. doi: 10.1007/s00228-009-0684-x. Epub 2009 Jun 25.

PMID:
19554320
16.

Transfer of buprenorphine into breast milk and calculation of infant drug dose.

Lindemalm S, Nydert P, Svensson JO, Stahle L, Sarman I.

J Hum Lact. 2009 May;25(2):199-205. doi: 10.1177/0890334408328295. Epub 2009 Jan 8.

PMID:
19136395
17.

Biological accelerator mass spectrometry at Uppsala University.

Salehpour M, Possnert G, Bryhni H, Palminger-Hallén I, Ståhle L.

Appl Radiat Isot. 2009 Mar;67(3):495-9. doi: 10.1016/j.apradiso.2008.08.001. Epub 2008 Aug 6.

PMID:
18789710
18.

[Risk of CNS adverse effects of aciclovir and valaciclovir. Watch the renal function in treatment of herpes simplex and herpes zoster].

Helldén A, Bergman U, Dwyer R, Medin C, Molanaei H, Ståhle L, Thylén P, Odar-Cederlöf I.

Lakartidningen. 2007 Jun 13-26;104(24-25):1916-20. Swedish. No abstract available.

PMID:
17674672
19.

AAPS-FDA workshop white paper: microdialysis principles, application and regulatory perspectives.

Chaurasia CS, Müller M, Bashaw ED, Benfeldt E, Bolinder J, Bullock R, Bungay PM, DeLange EC, Derendorf H, Elmquist WF, Hammarlund-Udenaes M, Joukhadar C, Kellogg DL Jr, Lunte CE, Nordstrom CH, Rollema H, Sawchuk RJ, Cheung BW, Shah VP, Stahle L, Ungerstedt U, Welty DF, Yeo H.

Pharm Res. 2007 May;24(5):1014-25. Epub 2007 Mar 27.

PMID:
17458685
20.

AAPS-FDA Workshop White Paper: microdialysis principles, application, and regulatory perspectives.

Chaurasia CS, Müller M, Bashaw ED, Benfeldt E, Bolinder J, Bullock R, Bungay PM, DeLange EC, Derendorf H, Elmquist WF, Hammarlund-Udenaes M, Joukhadar C, Kellogg DL Jr, Lunte CE, Nordstrom CH, Rollema H, Sawchuk RJ, Cheung BW, Shah VP, Stahle L, Ungerstedt U, Welty DF, Yeo H.

J Clin Pharmacol. 2007 May;47(5):589-603. No abstract available.

PMID:
17442685
21.

Efficacy of nelfinavir-based treatment in the central nervous system of HIV-1 infected patients.

Karlström O, Ståhle L, Perrin L, Tegude H, Sönnerborg A.

Scand J Infect Dis. 2006;38(5):371-4.

PMID:
16709540
23.

The aciclovir metabolite CMMG is detectable in the CSF of subjects with neuropsychiatric symptoms during aciclovir and valaciclovir treatment.

Helldén A, Lycke J, Vander T, Svensson JO, Odar-Cederlöf I, Ståhle L.

J Antimicrob Chemother. 2006 May;57(5):945-9. Epub 2006 Mar 15.

PMID:
16540518
24.

Identification of a novel specific CYP2B6 allele in Africans causing impaired metabolism of the HIV drug efavirenz.

Wang J, Sönnerborg A, Rane A, Josephson F, Lundgren S, Ståhle L, Ingelman-Sundberg M.

Pharmacogenet Genomics. 2006 Mar;16(3):191-8.

PMID:
16495778
25.

Interferon/pegylated interferon and ribavirin in HCV-associated kidney disease with or without cryoglobulinemia.

Bruchfeld A, Lindahl K, Stahle L, Schvarcz R.

J Hepatol. 2006 Feb;44(2):432-3; author reply 433. Epub 2005 Nov 21. No abstract available.

PMID:
16338023
26.

Pharmacogenetics of cyclophosphamide in patients with hematological malignancies.

Xie H, Griskevicius L, Ståhle L, Hassan Z, Yasar U, Rane A, Broberg U, Kimby E, Hassan M.

Eur J Pharm Sci. 2006 Jan;27(1):54-61. Epub 2005 Sep 23.

PMID:
16183265
27.

[The risk of Internet and lichens].

Ståhle L.

Lakartidningen. 2005 Aug 8-21;102(32-33):2242. Swedish. No abstract available.

PMID:
16145888
28.

Cerebrospinal fluid and plasma HIV-1 RNA levels and lopinavir concentrations following lopinavir/ritonavir regimen.

Yilmaz A, Ståhle L, Hagberg L, Svennerholm B, Fuchs D, Gisslén M.

Scand J Infect Dis. 2004;36(11-12):823-8.

PMID:
15764168
29.

High-dose ribavirin in combination with standard dose peginterferon for treatment of patients with chronic hepatitis C.

Lindahl K, Stahle L, Bruchfeld A, Schvarcz R.

Hepatology. 2005 Feb;41(2):275-9.

PMID:
15660393
30.

Efavirenz plasma concentrations in HIV-infected patients: inter- and intraindividual variability and clinical effects.

Ståhle L, Moberg L, Svensson JO, Sönnerborg A.

Ther Drug Monit. 2004 Jun;26(3):267-70.

PMID:
15167626
31.

Bile acid synthesis is increased in Chilean Hispanics with gallstones and in gallstone high-risk Mapuche Indians.

Gälman C, Miquel JF, Pérez RM, Einarsson C, Ståhle L, Marshall G, Nervi F, Rudling M.

Gastroenterology. 2004 Mar;126(3):741-8.

PMID:
14988828
32.

Evidence that plasma concentration rather than dose per kilogram body weight predicts ribavirin-induced anaemia.

Lindahl K, Schvarcz R, Bruchfeld A, Ståhle L.

J Viral Hepat. 2004 Jan;11(1):84-7.

PMID:
14738562
33.

Effect of probenecid and quinidine on the transport of alovudine (3'-fluorothymidine) to the rat brain studied by microdialysis.

Lindén K, Ståhle L, Ljungdahl-Ståhle E, Borg N.

Pharmacol Toxicol. 2003 Nov;93(5):226-32.

PMID:
14629734
34.

ME-609: a treatment for recurrent herpes simplex virus infections.

Harmenberg JG, Awan AR, Alenius S, Ståhle L, Erlandsson AC, Lekare G, Flink O, Augustsson E, Larsson T, Wikström AC, Stierna P, Field HJ, Larsson AG, Oberg B.

Antivir Chem Chemother. 2003 Jul;14(4):205-15.

PMID:
14582849
35.
36.

Interferon and ribavirin treatment in patients with hepatitis C-associated renal disease and renal insufficiency.

Bruchfeld A, Lindahl K, Ståhle L, Söderberg M, Schvarcz R.

Nephrol Dial Transplant. 2003 Aug;18(8):1573-80.

PMID:
12897097
37.

Acyclovir levels in serum and cerebrospinal fluid after oral administration of valacyclovir.

Lycke J, Malmeström C, Ståhle L.

Antimicrob Agents Chemother. 2003 Aug;47(8):2438-41.

38.
39.

Antiretroviral treatment of human immunodeficiency virus infection: Swedish recommendations.

Sandström E, Uhnoo I, Ahlqvist-Rastad J, Bratt G, Berglund T, Gisslén M, Lindbäck S, Morfeldt L, Ståhle L, Sönnerborg A; Swedish Consensus Group.

Scand J Infect Dis. 2003;35(3):155-67. Review.

PMID:
12751710
40.

High serum concentrations of the acyclovir main metabolite 9-carboxymethoxymethylguanine in renal failure patients with acyclovir-related neuropsychiatric side effects: an observational study.

Helldén A, Odar-Cederlöf I, Diener P, Barkholt L, Medin C, Svensson JO, Säwe J, Ståhle L.

Nephrol Dial Transplant. 2003 Jun;18(6):1135-41.

PMID:
12748346
41.

Sildenafil does not alter nelfinavir pharmacokinetics.

Bratt G, Ståhle L.

Ther Drug Monit. 2003 Apr;25(2):240-2.

PMID:
12657921
42.

Dosage of ribavirin in patients with hepatitis C should be based on renal function: a population pharmacokinetic analysis.

Bruchfeld A, Lindahl K, Schvarcz R, Ståhle L.

Ther Drug Monit. 2002 Dec;24(6):701-8.

PMID:
12451285
43.

Regulation of hepatic low-density lipoprotein receptor, 3-hydroxy-3-methylglutaryl coenzyme A reductase, and cholesterol 7alpha-hydroxylase mRNAs in human liver.

Rudling M, Angelin B, Ståhle L, Reihnér E, Sahlin S, Olivecrona H, Björkhem I, Einarsson C.

J Clin Endocrinol Metab. 2002 Sep;87(9):4307-13.

PMID:
12213890
44.

Quantitative pharmacogenetics of nortriptyline: a novel approach.

Kvist EE, Al-Shurbaji A, Dahl ML, Nordin C, Alván G, Ståhle L.

Clin Pharmacokinet. 2001;40(11):869-77.

PMID:
11735606
45.

Interferon and ribavirin therapy in dialysis patients with chronic hepatitis C.

Bruchfeld A, Ståhle L, Andersson J, Schvarcz R.

Nephrol Dial Transplant. 2001 Aug;16(8):1729. No abstract available.

PMID:
11477195
46.

Ribavirin treatment in dialysis patients with chronic hepatitis C virus infection--a pilot study.

Bruchfeld A, Ståhle L, Andersson J, Schvarcz R.

J Viral Hepat. 2001 Jul;8(4):287-92.

PMID:
11454181
47.
48.

[Reply: the factual matter is the most important].

Ståhle L, Sjönell G.

Lakartidningen. 2000 Dec 20;97(51-52):6107. Swedish. No abstract available.

PMID:
11195451
49.

[Mammography screening at the cross-roads--a proposal concerning the information to women].

Sjönell G, Ståhle L.

Lakartidningen. 2000 Nov 8;97(45):5150-3. Swedish. No abstract available.

PMID:
11116898
50.

Supplemental Content

Loading ...
Support Center